Sweeteners · Metabolic & Cardiometabolic
acesulfame-K does not increase blood glucose
Strong support Sweeteners 🔬 Includes disconfirming
Part of: • acesulfame-K
RefutedContestedStrong support
consensus score 0.85
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
10 support 1 contradict 0 tested null 2 mixed · 13 sources, 11 independent groups
What the evidence shows
Acesulfame-K is glycemically inert: it isn't metabolized for energy and RCTs plus a network meta-analysis of non-nutritive-sweetened beverages show no meaningful acute rise in glucose or insulin (blends containing Ace-K actually blunt the insulin response versus sugar). Its debated effects are on the microbiome/appetite, not on acute blood sugar.
The evidence (23)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Teysseire F, Bordier V, Beglinger C, Wölnerhanssen BK, Meyer-Gerspach AC 2024 · Nutrients | observational | supports | low | Narrative review: ace-K glycemically inert (not metabolized for energy). |
| Lin PY, Xie JR, Qian TC, Wang SS, Yu SY, Shi WB, Wang Y, Cen LZ, Zhu QJ, Zheng YY, Gao H, Fang R, Xia ZX, Liu AM, Xu L 2026 · International journal of molecular medicine | animal | contradicts | moderate | Chronic high-fat-diet mice given Ace-K (2 mg/mL, 12 weeks) developed impaired glucose tolerance and hepatic lipid accumulation via PLCβ activation in sweet-taste-receptor signaling, dependent on PPARα. |
| Lück A, Standl F, Stich H 2026 · Journal of medicine and life | meta-analysis | mixed | low | Systematic review/meta-analysis (22 studies) of artificial sweeteners in diabetics found higher insulin (g=0.50) and HbA1c (g=0.30) in common-effects models, but associations were not significant in random-effects models with substantial he |
| Čad EM et al 2026 · Nutrients | observational | supports | low | Narrative review synthesizing SWEET/SWITCH/Sweet Tooth European consortia RCTs: NNS consumption and sweet-taste exposure showed no adverse changes in glucoregulatory/endocrine biomarkers, cardiometabolic risk factors, or body weight. |
| Wölnerhanssen BK, Meyer-Gerspach AC, Beglinger C, Islam MS 2020 · Crit Rev Food Sci Nutr | observational | supports | moderate | Metabolic review: ace-K no meaningful glycemic effect. |
| Nichol AD, Holle MJ, An R 2018 · Eur J Clin Nutr | meta-analysis | supports | moderate | MA of NNS RCTs: no significant acute glycemic impact (incl. ace-K). |
| Rose BD, Pezos N, Choo JM, Wu T, Rogers GB, Ivey KL, Rayner CK, Young RL 2024 · Nutrients | animal | mixed | moderate | Mice given combined sucralose+acesulfame-K (2 weeks) showed 31% increased jejunal glucose absorption (3-OMG marker) independent of gut microbiota, but overall OGTT glycemic responses were NOT disrupted by NNS supplementation alone. |
| Almiron-Roig E, Navas-Carretero S, Castelnuovo G, Kjølbæk L, Romo-Hualde A, Normand M, Maloney N, Hardman CA, Hodgkins CE, Moshoyiannis H, Finlayson G, Scott C, Raats MM, Harrold JA, Raben A, Halford JCG, Martínez JA 2023 · Appetite | RCT | supports | moderate | SWEET beverages RCT: sucralose-acesulfame-K blend reduced 2-h insulin iAUC vs sucrose (no glucose rise). |
| Kossiva L, Kakleas K, Christodouli F, Soldatou A, Karanasios S, Karavanaki K 2024 · Nutrients | observational | contradicts | low | Narrative review states studies have associated artificial sweeteners' consumption with development of insulin resistance and NAFLD, among other effects, discussing chronic-use pros/cons generically. |
| Ahmad SY, Azad MB, Friel J, MacKay D 2019 · Curr Opin Clin Nutr Metab Care | observational | supports | low | Review of NNS RCTs: no adverse effect on glycemic control. |
| Pang MD, Bastings JJAJ, Jocken JWE, Harrold JA, Halford JCG, Kjølbæk L, Raben A, Adam TCM, Blaak EE, Goossens GH, SWEET consortium 2026 · International Journal of Obesity | RCT | supports | low | SWEET substudy RCT (n=83, 10-month weight-maintenance): sweeteners/sweetness-enhancers (S&SE) group showed no group differences in whole-body insulin sensitivity (oral glucose tolerance test) vs. sugar group, though some adipose lipolytic g |
| Kwan MG, Lipsky LM, Burger KS, Shearrer GE, Nansel TR 2025 · Nutrition research (New York, N.Y.) | observational | supports | low | Prospective cohort (n=365 pregnant women): non-nutritive sweetened beverage (NNSB) intake was not associated with fasting glucose or fasting insulin in 2nd trimester, adjusted for covariates. |
| Iizuka K 2022 · Nutrients | observational | mixed | low | Review: human meta-analyses find artificial sweeteners incl. Ace-K have no effect on glycemic control. |
| Zhang R, Noronha JC, Khan TA, McGlynn N, Back S, Grant SM, Kendall CWC, Sievenpiper JL 2023 · Nutrients | meta-analysis | supports | high | SR + network MA of non-nutritive-sweetened beverages: no meaningful postprandial glycemic/endocrine rise vs water under real-world conditions. |
| Begum RF, Nirenjen S, Rushendran R, Manisha M, Pavithra N, Sridevi S, Singh SA 2025 · Frontiers in nutrition | observational | supports | low | Narrative review states artificial sweeteners (aspartame, sucralose, stevia named; Ace-K implied in class) have minimal impact on blood glucose and do not cause hyperglycemia, useful for diabetes glycemic control. |
| Orku SE, Suyen G, Bas M 2023 · Nutrition | RCT | supports | moderate | RCT: regular low/no-calorie sweeteners did not impair glucose tolerance in healthy adults. |
| McGlynn ND, Khan TA, Wang L, Zhang R, Chiavaroli L, Au-Yeung F, Lee JJ, Noronha JC, Comelli EM, Blanco Mejia S, Ahmed A, Malik VS, Hill JO, Leiter LA, Agarwal A, Jeppesen PB, Rahelic D, Kahleová H, Salas-Salvadó J, Kendall CWC, Sievenpiper JL 2022 · JAMA Netw Open | meta-analysis | supports | moderate | RCT: NNS beverage vs sugar produced no adverse glycemic response. |
| Ahmad SY, Friel JK, Mackay DS 2020 · Nutr Rev | observational | supports | low | Review of NNS on glucose metabolism/gut hormones: acute glycemic impact negligible. |
| Kim S, Song Y 2025 · Nutrition Journal (BMC Nutr J) | observational | supports | low | Crossover CGM study (non-randomized, preference-based scheduling; n=66): 'zero cola' is not acesulfame-K alone -- 'its sweeteners consist of a blend of sucralose and acesulfame-K with no specific amounts.' Zero cola alone or with a muffin had minimal overall glycemic impact similar to muffin alone (iAUC180 113.3 vs 111.1 mmol·min/L, P=0.7832), but the authors themselves caveat: 'the specific type and composition of artificial sweeteners were not analyzed...since different artificial sweeteners have been linked to varying physiological effects, their metabolism may contribute to individual differences in glycemic responses.' No acesulfame-K-specific estimate exists in this paper; off-scope for a single-compound claim. |
| Flad E, Altstädt A, Beglinger C, Rehfeld JF, Van Oudenhove L, Wölnerhanssen BK, Meyer-Gerspach AC 2025 · Nutrients | RCT | supports | moderate | Randomized double-blind crossover trial (n=20): oral ace-K preload (0.1675 g) led to lower plasma glucose and insulin than sucrose preload, with ace-K not differing from water/xylitol on glucose. |
| Beigrezaei S, Hernández Vargas JA, Raeisi-Dehkordi H, Bridge LA, Chatelan A, Muka T, Galenkamp H, De Courten B, van den Born BH, Stronks K, Salehi-Abargouei A, Nicolaou M, Franco OH 2026 · European Journal of Nutrition | observational | contradicts | low | HELIUS prospective cohort (n=2612): higher non-sugar-sweetened beverage (NSSB, class including ace-K) intake was associated with increased incident type-2-diabetes risk (IRR 2.26), and substituting SSB with NSSB raised T2D risk in younger p |
| Odegaard AO, Chang J, Jiang L, Rashid S, Rydell S, Mitchell NR, Bantle AE, Seaquist E, Reikes A, Pereira MA 2026 · Diabetes care | RCT | supports | moderate | RCT (SODAS, n=179, T2D patients): substituting water for habitual artificially sweetened beverages (ASBs, commonly containing ace-K) over 24 weeks did NOT improve HbA1c or glycemic measures — the ASB arm's HbA1c was actually slightly lower |
| Galicia-Ayala C, Klünder-Klünder M, Vilchis-Ordoñez A, López-Martínez B, Miranda-Lora AL 2026 · Nutrition | RCT | supports | moderate | Randomized crossover trial (n=20): aspartame/acesulfame-K beverage (AAK) showed no significant differences in glucose, insulin, glucagon, GIP, PP, leptin, or ghrelin vs. carbonated water control over 120 min. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.